G. DOUGLAS CAMPBELL JR., B.A.; MARTIN H. STEINBERG, M.D., F.A.C.P.; JOHN D. BOWER, M.D., F.A.C.P.
Though the origins of erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency are rooted in human antiquity, the presence of drug-induced hemolysis in individuals subsequently felt to have G-6-PD deficiency was first reported in 1926 and the biochemical lesion responsible for this phenomenon elucidated in 1956 (1). In the United States, hemolysis induced by infection or drugs is the most common clinical manifestation of G-6-PD deficiency (2).
Ascorbic acid (vitamin C), an essential vitamin, is commonly used in pharmacologic doses for the prevention of the common cold and to promote the healing of wounds. We report here an individual with G-6-PD deficiency who
Learn more about subscription options.
Register Now for a free account.
CAMPBELL GD, STEINBERG MH, BOWER JD. Ascorbic Acid-Induced Hemolysis in G-6-PD Deficiency. Ann Intern Med. 1975;82:810. doi: 10.7326/0003-4819-82-6-810_1
Download citation file:
Published: Ann Intern Med. 1975;82(6):810.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only